作者
Verena Tscholl,Toshinori Chiba,Reza Wakili,Laura Rottner,David M. Leistner,Roth Esther,C Baldauf,Cerine Benachi,Alireza Sepehri Shamloo,Robert Hättasch,Patrick Nagel,Johannes Lucas,Martin Huemer,Ulf Landmesser,Nikolaos Dagres,Felix Hohendanner,Gerhard Hindricks,Philipp Attanasio
摘要
BACKGROUND: Pulsed Field Ablation (PFA) is a non-thermal ablation technology for atrial fibrillation. Several PFA systems are available, with distinct catheter designs and energy delivery protocols. Direct comparisons between PFA systems remain limited. OBJECTIVE: This study compared the procedural characteristics, safety, and efficacy of three contemporary PFA technologies in routine clinical practice. METHODS: ) were prospectively included. Freedom from any atrial arrhythmia (AA) was evaluated using 12-lead electrocardiography and 24-hour Holter at 3, 6 and 12 months, followed by routine clinical follow-up. RESULTS: A total of 198 patients (CMAC:91, VLCC:50, LTC: 57) were included. Acute PVI was achieved in all patients (median age, 68 [61.0, 76.0] years; 127 male (64.1%); 97 paroxysmal (49.0%)). The procedure and ablation times were longest in the LTC group. During a mean follow-up of 352.4±207.2 days, the estimated 12-month freedom from AA recurrence beyond the 8-week blanking period was comparable among the CMAC, VLCC, and LTC groups (76.9%, 71.6%, and 78.8%; log-rank p=0.72). In adjusted multivariable Cox regression, PFA system choice was not associated with AA recurrence (LTC vs. CMAC: HR 0.77, 95% CI 0.39-1.52, p=0.45; VLCC vs. CMAC: HR 1.16, 95% CI 0.58-2.34, p=0.67). One major complication (0.51%, ischemic stroke (CMAC)) occurred. CONCLUSION: In this prospective real-world study, PVI with the CMAC, VLCC, and LTC showed comparable efficacy and safety outcomes, while procedural profiles differed.